Metsä Tissue, part of Metsä Group, has announced a strategy update that includes an operational review with the target to improve internal efficiency, reduce complexity and focus on the tissue business.
In the second quarter of 2019, the company will book a mainly goodwill related impairment of approximately €102m.
In addition, it will book a restructuring provision of approximately €5m related to the ongoing and
already completed co-determination negotiations.
